REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Szalicilat Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Szalicilat Pharma Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Szalicilat Pharma Kft. is a company based in Hungary, with its head office in Budapest. The company operates in the Pharmacies and Drug Stores industry. The company was established on June 12, 2013. It currently has a total number of 4 (2024) employees. From the latest financial highlights, Szalicilat Pharma Kft. reported a net sales revenue increase of 5.32% in 2023. Its total assets grew by 19.74% over the same period. In 2023, Szalicilat Pharma Kft.’s net profit margin increased by 0.94%.

Headquarters
Vaci ut 134. b. ep.
Budapest; Budapest; Postal Code: 1138

Contact Details: Purchase the Szalicilat Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Szalicilat Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Szalicilat Pharma Kft. report to view the information.
Registered Capital:
Purchase the Szalicilat Pharma Kft. report to view the information.
Incorporation Date:
June 12, 2013
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Szalicilat Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.32%▲
Total operating revenue
5.41%▲
Operating profit (EBIT)
169.27%▲
EBITDA
112.68%▲
Net Profit (Loss) for the Period
1950%▲
Total assets
19.74%▲
Total equity
19.32%▲
Operating Profit Margin (ROS)
0.93%▲
Net Profit Margin
0.94%▲
Return on Equity (ROE)
15.25%▲
Quick Ratio
0.12%▲
Cash Ratio
0.07%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo